Clare Hodgson
Papers
1
Total Citations
58
H-Index
1
About
Clare Hodgson is a leading figure in drug discovery and assay development, with a primary focus on advancing high-throughput screening technologies. Her most cited work, "Achieving Accurate Compound Concentration in Cell-Based Screening: Validation of Acoustic Droplet Ejection Technology" (2009, 58 citations), represents a pivotal contribution to the field. In this study, Hodgson validated acoustic droplet ejection (ADE) as a precise, contactless method for delivering nanoliter volumes of compounds in cell-based assays, directly addressing a critical bottleneck in early-stage drug discovery—ensuring accurate compound concentrations to reduce false positives and improve reproducibility. This work has become a cornerstone reference for laboratories integrating ADE into their screening workflows, influencing best practices in assay miniaturization and liquid handling. Beyond this, Hodgson’s broader research spans assay optimization, compound management, and the development of robust cell-based models for phenotypic screening. Her contributions have helped shape modern screening paradigms, enabling more efficient and reliable identification of therapeutic candidates. With sustained impact evidenced by citations across pharmacology and biotechnology literature, Hodgson remains a respected authority whose work continues to guide researchers in achieving higher fidelity in drug discovery pipelines.
Research Focus
Key Achievements
Top Papers
- 1